NFE2L2 and amyotrophic lateral sclerosis: In ALS, in particular, a decrease in Nrf2 activity due to reduced expression or altered regulation leads to a reduction in antioxidant defenses, resulting in increased oxidative stress, protein aggregation, and motor neuron death.